I have spent time discussing the American political system and current events in Taiwan with the junior diplomats, and they have repeatedly expressed their country's desire to avoid confrontation with China.

There is no disputing the fact that American consumers pay 30 to 300 percent more for the same prescription drugs as our counterparts in Canada, Europe, and the rest of the world.

Estimates show that small businesses contribute 60-80 percent of the net new jobs annually.

For small businesses, regulatory burdens can be overwhelming.

The reason to split a court is for administrative purposes, and in the past there has been much debate about the liberal decisions of the Ninth Circuit and so forth; and people have wanted to get out of the Ninth Circuit for that reason.

I have long believed these types of collaborative agreements are a far better approach to federal land management than the contentious battles that too often sidetrack proper resource management.

While I recognize the great value and importance of prescription drugs and strongly support a continued U.S. focus on pharmaceutical research and development, our nation's seniors cannot be asked to subsidize the drug costs of other wealthy industrialized nations any longer.